Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Urgent action needed to tackle disposal of antibiotics - UN
Once consumed, most antibiotic drugs are excreted un-metabolised, along with resistant bacteria, through urine and faeces.
Study finds release of drugs into the environment is driving AMR

‘Careless’ disposal of antibiotics could lead to the emergence of ‘ferocious superbugs’ by driving antimicrobial resistance, according to United Nations (UN) experts.

Previous research has linked AMR to the misuse of antibiotics in humans and agriculture, but little attention has been given to the role of the environment and pollution.

This year’s Frontiers Report, released at the UN Environment Assembly in Nairobi, suggests the emergence and spread of AMR is being driven by antimicrobial compounds from homes, hospitals, pharmaceutical facilities and agricultural run-off being released into the environment; as well as direct contact between national bacterial communities and discharged resistant bacteria.

Once consumed, most antibiotic drugs are excreted un-metabolised, along with resistant bacteria, through urine and faeces, the report says.

Evidence also shows multi-drug resistant bacteria is prevalent in marine waters and sediments close to aquaculture, industry and municipal discharges.

“The warning here is truly frightening,” said Erik Solheim, chief of the UN Environment Programme. “We could be spurring the development of ferocious superbugs through ignorance and carelessness.”

Around 700,000 people die of resistant infections every year across the globe.

Mr Solheim continued: “This needs priority action right now, or else we run the risk of allowing resistance to occur through the back door, with potentially terrifying consequences.”

Solving the issue, according to the report, will involve tackling the use and disposal of antibiotics, as well as the release of antimicrobial drugs, contaminants and resistant bacteria into the environment.

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
BVA urges 'continued vigilance' over bluetongue

The British Veterinary Association (BVA) has urged vigilance following a concerning rise in Bluetongue (BTV) cases in sheep and cattle.

In a recent statement, the BVA noted that members are reporting more severe clinical signs and higher mortality rates than in previous years.

'We know that farm vets are working hard to support farmers and animals affected by this outbreak, during what is an extremely difficult time for all involved,' they stated. 'Continued vigilance to identify disease early is vital and vaccination remains the best way of protecting animals from this disease.'